Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay

Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay

Background: Lipoprotein particles with abnormal compositions, such as lipoprotein X (LP-X) and lipoprotein Z (LP-Z), have been described in cases of obstructive jaundice and cholestasis. The study objectives were to: (1) develop an NMR-based assay for quantification of plasma/serum LP-Z particles, (...

Full description

Bibliographic Details
Main Authors:	Shimpi Bedi, Erwin Garcia, Elias J. Jeyarajah, Irina Shalaurova, Maria Camila Perez-Matos, Z. Gordon Jiang, Robin P. F. Dullaart, Steven P. Matyus, William J. Kirk, James D. Otvos, W. Sean Davidson, Margery A. Connelly
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Journal of Clinical Medicine
Subjects:	lipoproteins nuclear magnetic resonance spectroscopy cholestasis liver disease
Online Access:	https://www.mdpi.com/2077-0383/9/9/2915

Similar Items

A High-Throughput NMR Method for Lipoprotein-X Quantification
by: Erwin Garcia, et al.
Published: (2024-01-01)

Detection of Lipoprotein X (LpX): A challenge in patients with severe hypercholesterolaemia
by: Ćwiklińska Agnieszka, et al.
Published: (2020-01-01)

The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
by: Trevor J. Orchard, et al.
Published: (2017-06-01)

A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort
by: Jose L. Flores-Guerrero, et al.
Published: (2020-08-01)

Lipoprotein a - Lp(a)
by: Tapan Ghose
Published: (2024-03-01)

A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X
by: Edward B. Neufeld, et al.
Published: (2022-08-01)

Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis
by: Rossella Colantuono, et al.
Published: (2022-08-01)

Nut consumption is associated with a shift of the NMR lipoprotein subfraction profile to a less atherogenic pattern among older individuals at high CVD risk
by: Jesús F. García-Gavilán, et al.
Published: (2022-09-01)

Evaluation of lipoprotein (a) [Lp(a)] and lipid abnormalities in patients with newly detected hypertension and its association with severity of hypertension
by: Subodh Kumar Mahto, et al.
Published: (2022-01-01)

The NIH Lipo-COVID Study: A Pilot NMR Investigation of Lipoprotein Subfractions and Other Metabolites in Patients with Severe COVID-19
by: Rami A. Ballout, et al.
Published: (2021-08-01)

LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans
by: John D. Bagdade, et al.
Published: (2018-05-01)

Lipoprotein(a) and multi-stage atherogenesis: coronary atherosclerosis, cerebrovascular complications and other correlations of Lp(a) and apo(a)
by: A. V. Tikhonov, et al.
Published: (2010-06-01)

Characterization and quantification of serum lipoprotein subfractions by capillary isotachophoresis: relationships with lipid, apolipoprotein, and lipoprotein levels
by: Alexandra Schlenck, et al.
Published: (1999-11-01)

Nuclear Magnetic Resonance-Measured Ionized Magnesium Is Inversely Associated with Type 2 Diabetes in the Insulin Resistance Atherosclerosis Study
by: Erwin Garcia, et al.
Published: (2022-04-01)

Human plasma lipoproteins /
by: Fruchart, J. C., et al.
Published: (1989)

Phospholipid transfer protein activity in two cholestatic patients
by: Eliana Cotta de Faria, et al.

Relationship Between Lipoprotein (a) [Lp(a)] and Cognition in Different Ischemic Stroke Subtypes
by: Jingjing Li, et al.
Published: (2021-12-01)

Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase
by: Shi-Qin Xiang, et al.
Published: (1999-09-01)

Neonatal cholestasis is an early liver manifestation of children with acid sphingomyelinase deficiency
by: Neng-Li Wang, et al.
Published: (2022-05-01)

Metabolic fate of rat and human lipoprotein apoproteins in the rat
by: Shlomo Eisenberg, et al.
Published: (1973-07-01)

A guidebook to lipoprotein technique /
by: 439775 Mills, G. L., et al.
Published: (1984)

Both LDL and HDL particle concentrations associate positively with an increased risk of developing microvascular complications in patients with type 2 diabetes: lost protection by HDL (Zodiac-63)
by: Arno R. Bourgonje, et al.
Published: (2023-07-01)

Lipoprotein particle distribution and skeletal muscle lipoprotein lipase activity after acute exercise
by: Harrison Michael, et al.
Published: (2012-07-01)

Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements
by: Calvin Yeang, et al.
Published: (2021-01-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Associations between intensive diabetes therapy and NMR-determined lipoprotein subclass profiles in type 1 diabetes[S]
by: Ying Zhang, et al.
Published: (2016-02-01)

High-Density Lipoprotein Particles and Torque Teno Virus in Stable Outpatient Kidney Transplant Recipients
by: Jip Jonker, et al.
Published: (2024-01-01)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
by: Peter Willeit, et al.
Published: (2020-12-01)

Lp(a) and inflammation: a new insight into atherosclerosis
by: Hangyu Pan, et al.
Published: (2023-10-01)

Coronary risk prediction by the correlation of total cholesterol/high-density lipoprotein, triglyceride/high-density lipoprotein, low-density lipoprotein/high-density lipoprotein ratios, non-high-density lipoprotein, apolipoprotein-B, and high-sensitivity C-reactive protein with low-density lipoprotein in Indian patients under statin therapy
by: A K Badrinath, et al.
Published: (2019-01-01)

Vantera Mediated Quantification of Urine Citrate and Creatinine: A New Technology to Assess Risk of Nephrolithiasis
by: Steven P. Matyus, et al.
Published: (2022-10-01)

Colestasis: un enfoque actualizado
by: Sergio del Valle Díaz, et al.

High-density lipoproteins : from basic biology to clinical aspects /
by: Fielding, Christopher J.
Published: (2007)

Prevalence of Hypoglycemia Among Patients Presenting with Cholestasis of Infancy in a Nigerian Teaching Hospital
by: Alphonsus N. Onyiriuka, et al.
Published: (2012-07-01)

High density Lipoprotein; What to Measure: Quality or Quantity?
by: Balasubramaniam Gayathri
Published: (2011-09-01)

BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS (BRIC)
by: S. Arulprakash, et al.
Published: (2010-03-01)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
by: Weili Zheng, et al.
Published: (2022-01-01)

Effect of an anti-lipoprotein lipase serum on plasma triglyceride removal
by: I P Kompiang, et al.
Published: (1976-09-01)

Alternations of Lipoprotein Profiles in the Plasma as Biomarkers of Huntington’s Disease
by: Kuo-Hsuan Chang, et al.
Published: (2023-01-01)

Evaluation of Staphylococcus aureus lipoproteins: Role in nutritional acquisition and pathogenicity
by: Shideh Vatani Shahmirzadi, et al.
Published: (2016-09-01)